Limited role of TP53 and TP53-related genes in myxoid liposarcoma

Tumori

Volumn 84, Issue 5, 1998, Pages 571-577

  Pilotti, Silvana ^a,d   Lavarino, Cinzia ^a   Mezzelani, Alessandra ^a   Della Torre, Gabriella ^b   Minoletti, Fabiola ^b   Sozzi, Gabriella ^b   Azzarelli, Alberto ^c   Rilke, Franco ^a   Pierotti, Marco A ^b  

^a Div of Anat Pathology and Cytology   (Italy)

^b Div Exp Oncol A   (Italy)

^c Div of Surg of Soft Tissue Tumors   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

cdk4; Cytogenetics; DNA and RNA analysis; Immunophenotyping; mdm2; Myxoid liposarcoma tumors; p53

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 12; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MYXOSARCOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0031672399     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400512     Document Type: Article

References (29)

1. Adams V., Kempf W., Hassam S., Briner J.: Determination of hexokinase isoenzyme I and II composition by RT-PCR: increased hexokinase isoenzyme II in human renal cell carcinoma. Biochem. Mol. Med., 54: 53-58, 1995
2. Altunsoz O., Meloni A.M., Peier A., Zalupski M., Spanier S., Brooks J.S.J., Sandberg A.A.: Deletion 6q in three cases of mixed-type liposarcoma in addition to t(12;16)(q13;11). Cancer Genet. Cytogenet., 79: 104-110, 1995.
3. Brooks J.J.: Disorders of soft tissue. In: Sternberg S.S. (Ed.), Diagnostic Surgical Pathology, 2nd ed., pp. 147-229, Raven, New York, 1994.
4. Dal Cin P., Kools P., Sciot R., De Wever I., Van Damme B., Van de Ven, W., Van Den Berghe H.: Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet. Cytogenet., 68: 85-90, 1993.
5. Dal Cin P., Sciot R., Panagopoulos I., Åman P., Samson I., Mandahl N., Mitelman F., Van Den Berghe H., Fletcher C.D.M.: Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J. Pathol., 182: 437-441, 1997.
6. Donghi R., Longoni A., Pilotti S., Michieh P., Della Porta G., Pierotti M.A.: Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest., 91: 1753-1760, 1993.
7. Evans H.L.: Liposarcoma. A study of 55 cases with a reassessment of its classification. Am. J. Surg. Pathol., 3: 507-523, 1979.
8. Gibas Z., Miettinen M., Limon J., Nedoszytko B., Mrozek K., Roszkiewicz A., Rys J., Niezabitowski A., Debiec-Rychter M.: Cytogenetic and immunohistochemical profile of myxoid liposarcoma. Am. J. Clin. Pathol., 103: 20-26, 1995.
9. Khatib Z.A., Matsushine H., Valentine M., Shapiro, D.N., Sherr C.J., Look A.T.: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53: 5535-5541, 1993.
10. Kilpatrick S.E., Doyon J., Choong P.F.M., Sim F.H., Nascimento A.G.: The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer, 77: 1450-1458, 1996.
11. Kindblom L.-G., Angervall L., Svendsen P.: Liposarcoma. A clinicopathologic, radiographic and prognostic study. Acta Pathol. Microbiol. Scand., 253 (supplement), Section A, 1975.
12. Klever M., Grond-Ginsbach C., Scherthan H., Schroeder-Kurth T.M.: Chromosomal in situ suppression hybridization after Giemsa banding. Hum. Genet., 86: 484-486, 1991.
13. Knight J.C., Renwick P.J., Dal Cin P., van den Berghe H., Fletcher C.D.M.: Translocation t(12;16) (q13:p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res., 55: 24-27, 1995.
14. Kuroda M., Ishida T., Horiuchi H., Kida N,. Uozaki H., Takeuchi H., Tsuji K., Imamura T., Mon S., Machinami R., Watanabe T.: Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am. J. Pathol., 147: 1221-1227, 1995.
15. Ladanyi M.: The emerging molecular genetics of sarcoma translocations. Diagn. Mol. Pathol., 4: 162-173, 1995.
16. Mentzel T., Fletcher C.D.M.: Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma. Histopathol., 30: 457-463, 1997.
17. Miozzo M., Sozzi G., Calderone C., Pilotti S., Lombardi L., Pierotti M.A., Della Porta G.: t(II;22) in three cases of peripheral neuroepithelioma. Genes Chrom. Cancer, 2: 163-165, 1990.
18. Mitelman F., Karger S. ISCN: Guidelines for Cancer Cytogenetics. Supplement to An International System for Human Cytogenetic Nomenclature. Basel: 1991.
19. Panagopoulos I., Höglund M., Mertens F., Mandahl N., Mitelman F., Åman P.: Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene, 12: 489-494, 1996.
20. Panagopoulos I., Mandahl N., Ron D., Höglund M., Nilbert M., Mertens F., Mitelman F., Åman P.: Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res., 54: 6500-6503, 1994.
21. Pilotti S., Della Torre G., Lavarino C., Di Palma S., Sozzi G., Minoletti F., Rao S., Pasquini G., Azzarelli A., Rilke F., Pierotti M.A.: Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J. Pathol., 181: 14-24, 1997.
22. Pilotti S., Della Torre G., Lavarino C., Sozzi G., Minoletti F., Vergani B., Azzarelli A., Rilke F., Pierotti M.A.: Molecular abnormalities in liposarcoma: role of MDM2 and CDK4 containing amplicons at 12q13-22. J. Pathol., 185: 188-190, 1998.
23. Pinkel D., Straume T., Gray J.W.: Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA, 83: 2934-2938, 1986.
24. Sreekantaiah C., Karakousis C.P., Leong S.P.L., Sandberg A.A.: Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer, 69: 2484-2495, 1992.
25. Suijkerbuijk R.F., Olde Weghuis D.E.M., Van Den Berg M., Pedeutour F., Forus A., Myklebost O., Glier C., Turc-Carel C., van Kessel A.G.: Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas. Genes Chrom. Cancer, 9: 292-295, 1994.
26. Tallini G., Akerman M., Dal Cin P, DeWever I., Fletcher C.D.M., Mandahl N., Mertens F., Mitelman F., Rosai J., Rydhom A., Sciot R., Van Den Berghe H., Van Den Ven W., Vanni R., Willen H.: Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing (a report from the CHAMP Group). Am. J. Surg. Pathol., 20:1047-1055, 1996.
27. Turc-Carel C., Limon J., Dal Cin P., Rao U., Karakousis C., Sandberg A.A.: Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12,16) (q13;p11) in myxoid liposarcomas. Cancer Genet. Cytogenet., 23: 291-300, 1986.
28. Wolf M., Aaltonen L.A., Szymanska J., Tarkkanen M., Elomaa I., Knuutila S.: Microsatellite markers as tools for characterization of DNA amplifications evaluated by comparative genomic hybridization. Cancer Genet. Cytogenet., 93: 33-38, 1997.
29. Zinszner H., Abalat R., Ron D.: A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev., 8: 2513-2526, 1994.